Cannabix Technologies Expands Marijuana Breathalyzer Portfolio With Licensing of UBC Technology for Workplace and Parental Use

UF startup Cannabix Technologies Inc., developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, reported that the Company has entered into an exclusive license agreement with the University of British Columbia (UBC) to use and commercialize certain technology for the detection of volatile organic compounds for testing (to be used for marijuana breathalyzer purposes) owned by UBC and developed by Dr. Mina Hoofar and her team of researchers at the UBC Okanagan School of Engineering.

The patent-pending UBC technology, known as THC Breath Analyzer (THCBA), incorporates highly sensitive microfluidic sensors that can be manufactured at relatively low cost. This exclusive technology license will allow for Cannabix to offer a complementary low-cost portable breathalyzer device that would be ideally suited for workplace, parental and personal use testing. Cannabix’s advanced FAIMS (field asymmetric waveform ion mobility spectrometry), based marijuana breathalyzer system, will be primarily focussed on roadside testing with law enforcement and toxicology lab confirmation. Significant development work has been accomplished on the THCBA by UBC and images of the portable device (under development) can be viewed at cannabixtechnologies.com.

Learn more about Cannabix Technologies Expands Marijuana Breathalyzer Portfolio With Licensing of UBC Technology for Workplace and Parental Use.